SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Arsanis, Inc. – ‘8-A12B’ on 11/15/17

On:  Wednesday, 11/15/17, at 8:53am ET   ·   Accession #:  1193125-17-343308   ·   File #:  1-38295

16 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

11/15/17  Arsanis, Inc.                     8-A12B                 1:13K                                    Donnelley … Solutions/FA

Registration of a Class of Securities   —   Form 8-A
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-A12B      Registration of a Class of Securities               HTML     11K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  Form 8-A12B  

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-A

 

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

Arsanis, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   27-3181608
(State of incorporation or organization)   (I.R.S. Employer Identification No.)

 

890 Winter Street, Suite 230

Waltham, Massachusetts

  02451
(Address of principal executive offices)   (Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class

to be so registered

 

Name of each exchange on which

each class is to be registered

Common stock, par value $0.001 per share   The NASDAQ Stock Market LLC

 

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box.  ☒

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box.  ☐

Securities Act registration statement or Regulation A offering statement file number to which this form relates: 333-221050

Securities to be registered pursuant to Section 12(g) of the Act: None.

 

 

 


Item 1. Description of Registrant’s Securities to be Registered.

The description under the heading “Description of Capital Stock” relating to the Registrant’s common stock par value, $0.001 per share, in the prospectus included in the Registrant’s Registration Statement on Form S-1 (File No. 333-221050), as amended (the “Registration Statement”), filed under the Securities Act of 1933, as amended (the “Securities Act”), with the Securities and Exchange Commission (the “Commission”) is incorporated herein by reference. Any form of prospectus subsequently filed by the Registrant with the Commission pursuant to Rule 424(b) under the Securities Act that constitutes part of the Registration Statement shall be deemed to be incorporated herein by reference.

Item 2. Exhibits.

Pursuant to the Instructions as to Exhibits for Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.


SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

Arsanis, Inc.
By:   /s/ René Russo
  René Russo
  President and Chief Executive Officer

Dated: November 15, 2017


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-A12B’ Filing    Date    Other Filings
Filed on:11/15/17None on these Dates
 List all Filings 


16 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/14/23  X4 Pharmaceuticals, Inc.          S-3         8/11/23    4:797K                                   Workiva Inc Wde… FA01/FA
 6/21/23  X4 Pharmaceuticals, Inc.          424B3       6/20/23    1:235K                                   Donnelley … Solutions/FA
12/09/22  X4 Pharmaceuticals, Inc.          424B5      12/08/22    1:643K                                   Donnelley … Solutions/FA
12/07/22  X4 Pharmaceuticals, Inc.          424B5                  1:645K                                   Donnelley … Solutions/FA
 8/05/22  X4 Pharmaceuticals, Inc.          424B3                  1:184K                                   Donnelley … Solutions/FA
 7/29/22  X4 Pharmaceuticals, Inc.          424B3                  1:111K                                   Workiva Inc Wde… FA01/FA
 7/29/22  X4 Pharmaceuticals, Inc.          S-3                    4:285K                                   Donnelley … Solutions/FA
 4/22/22  X4 Pharmaceuticals, Inc.          S-3                    4:281K                                   Workiva Inc Wde… FA01/FA
 1/14/22  X4 Pharmaceuticals, Inc.          424B5                  1:569K                                   Donnelley … Solutions/FA
 1/04/22  X4 Pharmaceuticals, Inc.          424B3                  1:139K                                   Donnelley … Solutions/FA
12/23/21  X4 Pharmaceuticals, Inc.          S-3                    3:231K                                   Donnelley … Solutions/FA
 7/12/21  X4 Pharmaceuticals, Inc.          424B3                  1:162K                                   Donnelley … Solutions/FA
 6/25/21  X4 Pharmaceuticals, Inc.          S-3                    4:445K                                   Donnelley … Solutions/FA
10/19/20  X4 Pharmaceuticals, Inc.          S-3                    7:1M                                     Donnelley … Solutions/FA
10/16/20  X4 Pharmaceuticals, Inc.          424B5                  1:539K                                   Donnelley … Solutions/FA
 8/07/20  X4 Pharmaceuticals, Inc.          S-3                    8:1.3M                                   Donnelley … Solutions/FA
Top
Filing Submission 0001193125-17-343308   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 6:18:10.2pm ET